VANCOUVER: Redfund Capital Corp. announced that its portfolio client Sunshine State Tea will begin manufacturing its lineup of CBD & vitamin infused teas as Washington State reopens. Although still in a cautious stage of restarting, three more Washington state counties last week received approval to move into the next phase of the state’s Safe Start…
TORONTO: Graph Blockchain Inc. applauds Datametrex Limited for securing the rights to import COVID-19 detection kit into Canada and other countries around the globe. Datametrex, a minority shareholder of Graph Blockchain, is currently working with Health Canada to have the approval of these kits fast-tracked. President & COO, Christian Scovenna added: “On behalf of the…
LONDON, UK: The Board of Dechra Pharmaceuticals has announced the acquisition of Ampharmco LLC (APC) and its associated holding companies, Dragon Fire Holdings LLC and Black Griffin Holdings LLC together with its manufacturing site based in Fort Worth, Texas, for a cash consideration of USD 30.0 million (£24.5 million). APC was originally founded in 1999…
LONDON: UK-based clinical-stage biotech Scancell Holdings plc (AIM: SCLP) has agreed to acquire Nasdaq-listed Neuphoria Therapeutics Inc. (Nasdaq: NEUP) in an all-share merger, the companies announced today. Once the deal closes, the combined business will keep the Scancell name and plans to list on Nasdaq under the ticker “SCLT.” The merger is being paired with a substantial capital…
PARIS: Ipsen (Euronext: IPN; ADR: IPSEY) and Memo Therapeutics AG announced today they have entered into a definitive share purchase agreement. Under the terms, Ipsen will acquire all outstanding shares of Memo Therapeutics, with a primary focus on advancing the Phase II asset, potravitug. The acquisition centers on a promising antibody designed to combat the BK polyomavirus (BKPyV)—a…
LONDON – Biogen Inc. (“Biogen”, Nasdaq: BIIB) has entered into a definitive agreement to acquire public portfolio company Apellis Pharmaceuticals, Inc. (“Apellis”, Nasdaq: APLS). Apellis is a commercial-stage biotech advancing treatments for serious, complement-driven diseases. It has two FDA-approved medicines, EMPAVELI® for rare immune-mediated kidney diseases and SYFOVRE® for an immune-mediated retinal disease. According to…
WURMLINGEN – Companion Spine LLC, the French-American spine implant surgery specialist, announced on Tuesday the completion of its acquisition of the Paradigm Spine business globally from Xtant Medical Holdings, Inc. (NYSE: XTNT). The deal includes the flagship Coflex® Interlaminar Stabilization® device and CoFix® fusion system, along with all related subsidiaries and global business activities. The combined…
LONDON: Partners Group Private Equity Limited (PGPE Ltd) announced Monday the sale of Clario, a leading provider of clinical trial data solutions, to Thermo Fisher Scientific. The transaction, subject to customary regulatory approvals, is expected to close by the end of the second quarter of 2026. Clario, headquartered in Philadelphia, is PGPE Ltd’s eighth-largest portfolio…
SEATTLE: AI Technology Group Inc. (OTCID: AIPG) said Friday it has filed an amended Form 10 with the U.S. Securities and Exchange Commission and signed a definitive agreement to acquire AVM Biotechnology Inc., a clinical-stage biopharmaceutical company developing a novel cancer therapy. Under the agreement dated July 31, 2025, a newly formed subsidiary of AI…
Migrant workers in Canada are experiencing severe delays in processing their work permits and residency applications, leaving many without legal status, access to health care, or the right to work—forcing some into exploitative situations, according to interviews and government data obtained by Reuters. The growing backlog in immigration applications, coupled with shifting policies, has left…
NEW YORK: Cosette Pharmaceuticals, Inc., a U.S.-based pharmaceutical company, announced Thursday that it has entered into a definitive agreement to acquire all outstanding shares of Mayne Pharma Group Limited (ASX: MYX) for AUD $7.40 per share. The total consideration for the transaction is approximately USD $430 million. The Boards of Directors of both companies have…
SALT LAKE CITY: Cotiviti, a leader in data-driven healthcare solutions, announced today that it has entered into an agreement to acquire Edifecs, a pioneer in healthcare data interoperability. The combined platform aims to enhance connectivity between payers and providers, increase collaboration in the delivery of care, and accelerate the deployment of value-added solutions within the…